Earnings Yield and Valuation Review For Medtronic plc (NYSE:MDT) as EBITDA Hits 0.065942

In terms of EBITDA Yield, Medtronic plc (NYSE:MDT) currently has a value of 0.065942. This value is derived by dividing EBITDA by Enterprise Value.

Investors are typically trying to find solid stocks to add to the portfolio. When it comes to stock picking, there is no magic formula. There are various techniques that may provide better outcomes than others, but it’s how these techniques are put together and applied that can make all the difference. One of the keys to successful investing is the proper use of information. Everyone can see the vast amount of data that is available on publically traded companies. Being able to interpret the data could end up being the most important factor when it comes to successfully selecting stocks to buy. Taking the time to investigate a particular stock that looks attractive can be a smart move. Investors may be better served to not just jump on the hot stock of the day, but employ analysis that may help uncover some buried information. Good stocks are indeed out there, it may just take some time to figure out which ones they are.

Piotroski F-Score

The Piotroski F-Score is a scoring system between 1-9 that determines a firm’s financial strength. The score helps determine if a company’s stock is valuable or not. The Piotroski F-Score of Medtronic plc (NYSE:MDT) is 8. A score of nine indicates a high value stock, while a score of one indicates a low value stock.

The score is calculated by the return on assets (ROA), Cash flow return on assets (CFROA), change in return of assets, and quality of earnings. It is also calculated by a change in gearing or leverage, liquidity, and change in shares in issue. The score is also determined by change in gross margin and change in asset turnover.

The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years.  The score is a number between one and one hundred (1 being best and 100 being the worst).  The Gross Margin Score of Medtronic plc (NYSE:MDT) is 36.00000.  The more stable the company, the lower the score.  If a company is less stable over the course of time, they will have a higher score.

Price Index

The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Medtronic plc (NYSE:MDT) for last month was 1.01962. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Medtronic plc (NYSE:MDT) is 1.15407.

Another useful indicator to assist in detmining rank is the ERP5 Rank.  This is an investment tool that analysts use to discover undervalued companies.  The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.  The ERP5 of Medtronic plc (NYSE:MDT) is 4136.  The lower the ERP5 rank, the more undervalued a company is thought to be.

Looking further, the MF Rank (aka the Magic Formula) is a formula that pinpoints a valuable company trading at a good price.  The formula is calculated by looking at companies that have a high earnings yield as well as a high return on invested capital.  The MF Rank of Medtronic plc (NYSE:MDT) is 4263.  A company with a low rank is considered a good company to invest in.  The Magic Formula was introduced in a book written by Joel Greenblatt, entitled, “The Little Book that Beats the Market”.

Earnings Yield

The Earnings to Price yield of Medtronic plc NYSE:MDT is 0.038684. This is calculated by taking the earnings per share and dividing it by the last closing share price. This is one of the most popular methods investors use to evaluate a company’s financial performance. Earnings Yield is calculated by taking the operating income or earnings before interest and taxes (EBIT) and dividing it by the Enterprise Value of the company. The Earnings Yield for Medtronic plc NYSE:MDT is 0.047841. Earnings Yield helps investors measure the return on investment for a given company. Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value. The Earnings Yield Five Year average for Medtronic plc (NYSE:MDT) is 0.038758.

ROIC

The Return on Invested Capital (aka ROIC) for Medtronic plc (NYSE:MDT) is 0.442400.  The Return on Invested Capital is a ratio that determines whether a company is profitable or not.  It tells investors how well a company is turning their capital into profits.  The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital.  The employed capital is calculated by subrating current liabilities from total assets.  Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years.  The ROIC Quality of Medtronic plc (NYSE:MDT) is 2.985083.  This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC.  The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets).  The ROIC 5 year average of Medtronic plc (NYSE:MDT) is 0.363673.

The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of Medtronic plc (NYSE:MDT) is 53.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of Medtronic plc (NYSE:MDT) is 45.

Investors may be taking a look at certain business aspects when attempting to research a stock. Investors often look to see if the stock’s specific industry is on the rise. There may be a greater chance of success when investing in an industry that is rapidly growing. Investors may then want to see how the company stacks up within the industry. Many investors will look for stocks that are proven industry leaders. Industry leaders have the ability to influence pricing and not necessarily be susceptible to what other companies are doing around them. Investors may also be taking note of how a company invests in research and development. Companies that are focused on the future may have a competitive advantage over those who are too focused on the near-term.